Current Opinion in Rheumatology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Rheumatology is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
EDITOR IN CHIEF
Gary S. Hoffman
Dr Gary Hoffman received his medical degree from the Medical College of Virginia, USA, and pursued advanced training in medicine and rheumatology at the Dartmouth Medical School-Mary Hitchcock Clinic, USA. In being first a clinician, patient experiences steered his research in many unrelated directions, including calcium oxalate arthropathy in ESRD, inflammatory muscle disease, arachnoiditis and lupus. After 13 years in general rheumatology at Dartmouth-Hitchcock Medical Center, the Army and the Mary Imogene Bassett Hospital in Cooperstown, NY, USA, in 1987, he joined Dr Anthony Fauci's Vasculitis and Related Diseases Section at the NIH from 1987 to 1992. He became the head of that section and has since focused on vasculitis care and research.
In 1992 he became the Chairman of the Department of Rheumatic and Immunologic Diseases from 1992 to 2008 at the Cleveland Clinic (CC), USA, where he has been the Harold C. Schott Chair until 2011. He is the Founder of the Cleveland Clinic Center for Vasculitis Care and Research, Founder and past Chairman of the International Network for the Study of the Systemic Vasculitides (INSSYS) and Professor of Medicine at the CC Lerner College of Medicine, USA. He has led investigations of new therapies for vasculitis and coordinated INSSYS-based multi-center studies of diagnostic laboratory and imaging tools to assess vasculitis disease activity. His major current interest is related to factors that may be involved in determining organ vulnerability and selective targeting.
Dr Hoffman has authored over 290 articles and chapters and edited 3 books, including the recently released 2nd edition of Inflammatory Diseases of Blood Vessels. Past awards include the NIH Director's Award, the NIAID Director's Award, Wegener's Foundation Award, William Ischmael Award, Pemberton Award, Ira Goldstein Memorial Lecture Award (NYU), Sam and Maria Miller Award for excellence in clinical research, as well as awards for teaching. Dr Hoffman serves on Editorial Boards of numerous rheumatology journals, and is the Editor of Current Opinion in Rheumatology. He has served on the Board of the Vasculitis Foundation and several non-profit organizations that provide medical care and education for the under-served. He is a former ACR Board member, the 2010 ACR Distinguished Clinical Investigator and a Master of the ACR.
Prof. Alfred Mahr was appointed Chief of Internal Medicine at Hospital Saint-Louis at the University Paris 7-Diderot in Paris, France, in 2010. His major interest is in providing clinical care for patients with systemic vasculitides (e.g., ANCA-associated vasculitis, giant cell arteritis, Behçet's disease, Henoch-Schönlein purpura), connective tissue diseases and other multi-systemic rheumatic disorders. He received a MPH degree and a PhD degree in public health-epidemiology. Prof. Mahr's research focuses on the elucidation of the epidemiology and etiology and on diagnostic and therapeutic aspects of systemic vasculitides. He was actively involved in many studies of the French Vasculitis Study Group (FVSG), the European Vasculitis Study Group (EUVAS) as well as the North American Vasculitis Clinical Research Consortium (VCRC). He has authored and co-authored about 120 peer-reviewed articles and book chapters. Prof. Mahr has served as an Associate Editor for Rheumatology (Oxford) since 2011.
Ellen M. Gravallese
Dr Ellen M. Gravallese is the Myles J. McDonough Chair in Rheumatology and Professor of Medicine and Cell and Developmental Biology at the University of Massachusetts Medical School, USA. She serves as Chief of the Division of Rheumatology and Director of Translational Research for the Musculoskeletal Center of Excellence. Dr Gravallese received her AB degree from Harvard College, USA, magna cum laude, and her MD from Columbia University College of Physicians and Surgeons, USA, Alpha Omega Alpha. She completed a combined residency in internal medicine and pathology at Brigham and Women's Hospital, Harvard Medical School, USA, where she also served as a fellow in the Division of Rheumatology, Immunology and Allergy. She is Board Certified in Anatomic Pathology, Internal Medicine and Rheumatology. Dr Gravallese's career focus has been in the areas of basic science investigation, the care of patients with rheumatic diseases, and the training of young investigators and rheumatology fellows. Dr Gravallese's basic science laboratory has been devoted for the past 20 years to the study of the pathogenesis of rheumatoid arthritis (RA), with a particular interest in the fundamental mechanisms of bone destruction. Her research has identified key molecular and cellular pathways in the erosion of bone in RA and has contributed to the realization of new therapeutic agents, as well as to a change in focus of the treatment of RA towards disease modification, in addition to control of inflammation. Her trainees have gone on to positions including Professor of Medicine and Director of Rheumatology Fellowship Training, and many are accomplished researchers in their own right.
Dr Gravallese is the recipient of the Marion Ropes physician achievement award from the Arthritis Foundation, the Sandoz Award for medical research, and the Physician Achievement Award from the University of Massachusetts. Dr Gravallese has served on the Board of Directors of the American College of Rheumatology (ACR) and the Research and Education Foundation of the ACR. She also served as Chair of the ACR's Committee on Journal Publications. She lectures nationally and internationally and her research has been supported by the National Institutes of Health, the American College of Rheumatology and the Arthritis Foundation, as well as other agencies and foundations.